Tocilizumab in COVID-19: Is the Temptation Worthwhile?

How to cite this article: Gupta S, Tomar DS. Tocilizumab in COVID-19: Is the Temptation Worthwhile? Indian J Crit Care Med 2021;25(3): 247–248.

Detalles Bibliográficos
Autores principales: Gupta, Sachin, Tomar, Deeksha S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991758/
https://www.ncbi.nlm.nih.gov/pubmed/33790498
http://dx.doi.org/10.5005/jp-journals-10071-23750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991758/
https://www.ncbi.nlm.nih.gov/pubmed/33790498
http://dx.doi.org/10.5005/jp-journals-10071-23750

Ejemplares similares